Oxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Up 131.0% in February

Oxford Biomedica plc (OTCMKTS:OXBDF) was the target of a large growth in short interest in the month of February. As of February 28th, there was short interest totalling 78,300 shares, a growth of 131.0% from the February 13th total of 33,900 shares. Currently, 0.1% of the company’s shares are sold short. Based on an average daily volume of 4,600 shares, the days-to-cover ratio is currently 17.0 days.

Oxford Biomedica Stock Performance

Shares of OTCMKTS:OXBDF opened at $3.53 on Friday. The company has a current ratio of 2.35, a quick ratio of 2.07 and a debt-to-equity ratio of 1.48. Oxford Biomedica has a 1 year low of $2.40 and a 1 year high of $5.68. The stock has a 50-day simple moving average of $4.83 and a 200-day simple moving average of $4.97.

About Oxford Biomedica

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.